HomeNewsIndiaUS lawmakers and governors push for more COVID vaccines to India

US lawmakers and governors push for more COVID vaccines to India

India on Sunday reported 1,14,460 new coronavirus infections, the lowest in 60 days, while the daily positivity rate stood at 5.62 per cent. The total tally of coronavirus cases in the country is 2,88,09,339.

June 07, 2021 / 08:18 IST
Story continues below Advertisement
The NASDAQ-listed Ocugen has rights to commercialise Covaxin in the US.
The NASDAQ-listed Ocugen has rights to commercialise Covaxin in the US.

Several lawmakers and governors have urged the Biden administration to ensure India receives Covid vaccines and medical aid, saying the crisis in the country is ''devastating'' and that the US has a responsibility to help its close allies fight the pandemic.

India on Sunday reported 1,14,460 new coronavirus infections, the lowest in 60 days, while the daily positivity rate stood at 5.62 per cent. The total tally of coronavirus cases in the country is 2,88,09,339.

Story continues below Advertisement

''The crisis in India is devastating and demands more action from (US President Joe) Biden. More COVID-19 vaccines and medical supplies are needed to help one of our most important global allies fight this virus,'' Texas Governor Greg Abbott said.

In a tweet, he urged US citizens to join him in praying for India.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show